THERMO FISHER SCIENTIFIC INC. (NYSE:TMO) Files An 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain OfficersItem 5.02
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.
On July 12, 2017, the Board of Directors of Thermo Fisher Scientific Inc. (the “Company”) appointed Mark P. Stevenson Executive Vice President and Chief Operating Officer, effective August 1, 2017. In this new role, Mr. Stevenson will now have operational oversight of the Company’s Laboratory Products and Analytical Instruments businesses in addition to his current responsibility for the Life Sciences Solutions business. Mr. Stevenson, 54, was appointed Executive Vice President and President, Life Sciences Solutions in February 2014 upon the Company’s acquisition of Life Technologies Corporation (“Life Technologies”). Mr. Stevenson was President and Chief Operating Officer of Life Technologies from November 2008 to February 2014 and previously President and Chief Operating Officer of Applied Biosystems, Life Technologies’ predecessor entity, from December 2007 to November 2008. The required disclosure regarding the vesting of certain legacy Life Technologies equity held by Mr. Stevenson was previously included in the Company’s definitive proxy statement on Form 14A filed with the SEC on April 4, 2017 and is incorporated herein by reference.
Also on July 12, 2017, Thomas W. Loewald, a named executive officer of the Company, notified the Company of his decision to resign effective September 1, 2017.
About THERMO FISHER SCIENTIFIC INC. (NYSE:TMO)
Thermo Fisher Scientific Inc. develops, manufactures and sells a range of products. The Company is a provider of analytical instruments, equipment, reagents and consumables, software and services for research, manufacturing, analysis, discovery and diagnostics. The company operates through four segments: Life Sciences Solutions, Analytical Instruments, Specialty Diagnostics, and Laboratory Products and Services. Through the Life Sciences Solutions segment, it provides reagents, instruments and consumables used in biological and medical research, discovery and production of new drugs and vaccines, as well as diagnosis of disease. Through the Analytical Instruments segment, it provides instruments, consumables, software and services. The Specialty Diagnostics segment offers diagnostic test kits, reagents, culture media, instruments and associated products. The Laboratory Products and Services segment offers self-manufactured and sourced products for the laboratory.